Dow Down 1.10% Nasdaq Down 1.82%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
4.60 Down 0.47(9.27%) Feb 8, 4:00PM EST
|After Hours : 4.63 Up 0.03 (0.65%) Feb 8, 7:50PM EST
Prev Close:5.07
Open:5.01
Bid:N/A
Ask:4.63 x 2300
1y Target Est:7.88
Beta:1.64489
Next Earnings Date:23-Feb-16ARIA Earnings announcement
Day's Range:4.57 - 5.02
52wk Range:4.57 - 10.07
Volume:4,058,438
Avg Vol (3m):3,448,030
Market Cap:870.75M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 9.27%870.75M
PFEDown 1.62%176.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.24
Quarterly EPS Est (Dec-15) :-0.31
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback